Todas as matérias desta seção, das mais recentes às mais antigas — página 276 de 371.
Repligen (NASDAQ:RGEN) reported fourth-quarter results that surpassed analyst forecasts, providing fresh evidence that the bioprocessing industry is successfully moving past its post-pandemic destocking phase.
Houston-based Westlake Chemical Partners (NYSE:WLKP), the master limited partnership that owns a 13.3% limited partner interest in Westlake Chemical OpCo LP, which operates ethylene production facilities, reported fourth-quarter and full-year 2025 financial results on February 24, 2026.
China Yuchai International (NYSE:CYD) reported a significant expansion in its fiscal 2025 results, as a recovery in China’s commercial vehicle sector and a shift toward high-horsepower engines drove record unit sales and margin expansion.
Coca-Cola FEMSA (NYSE:KOF) reported a sharp rise in fourth-quarter profitability, as the bottling giant leaned on price increases and digital distribution initiatives to overcome volume sluggishness in key North American markets.
CECO Environmental (NASDAQ:CECO), a provider of engineered solutions for air pollution control, industrial ventilation and fluid handling, reported strong fourth-quarter and full-year 2025 financial results.
Ferguson Enterprises (NYSE:FERG), a leading distributor of plumbing and heating products, infrastructure and industrial supplies in North America, reported strong full-year 2025 financial results
Life Time Group Holdings (NYSE:LTH) reported record financial results for fiscal 2025, buoyed by a surge in high-margin membership dues and increased in-center spending.
Orthofix Medical (NASDAQ:OFIX) delivered a pivotal fourth quarter to close out fiscal 2025, reaching a long-sought milestone of positive annual free cash flow while reporting a 10% jump in its global spine fixation business.
Fulcrum Therapeutics (NASDAQ:FULC) reported fourth-quarter and full-year 2025 results highlighted by positive 12-week data for its lead candidate, pociredir.
Beam Therapeutics (NASDAQ:BEAM), a biotechnology company developing precision genetic medicines through base editing, reported fourth-quarter and full-year 2025 financial results on February 24, 2026.
Alpharetta, Georgia-based Avanos Medical (NYSE:AVNS), a medical technology company focused on pain management and chronic care solutions, reported fourth-quarter and full-year 2025 financial results on February 24, 2026.
Atlanta-based Havertys Furniture Companies (NYSE:HVT), a leading regional retailer of residential furniture and accessories, reported solid fourth-quarter and full-year 2025 financial results on February 24, 2026.
Xometry (NASDAQ:XMTR) reported a record-breaking fourth quarter to cap a year of significant operational inflection, as the company’s AI-native marketplace officially established a trajectory of sustained profitability on an adjusted basis.
American Tower (NYSE:AMT) reported a resilient finish to fiscal 2025, driven by record fourth-quarter revenue and robust demand for its distributed real estate.
Dillard’s (NYSE:DDS) reported a resilient fiscal 2025 performance, maintaining its high-margin retail model despite a fourth quarter hampered by severe winter weather.
Burlington, Massachusetts-based Keurig Dr Pepper (NASDAQ:KDP), a producer and distributor of hot and cold beverages in North America, reported strong full-year 2025 financial results and provided an optimistic 2026 outlook on February 24, 2026.
Constellation (NASDAQ:CEG), the nation's largest producer of carbon-free energy and a leading supplier of clean energy to commercial and public sector customers, reported robust fourth-quarter and full-year 2025 financial results on February 24, 2026.
Brightstar Lottery (NYSE:BRSL), an operator of lottery systems and services following its strategic transformation, reported fourth-quarter and full-year 2025 financial results on February 24, 2026, reflecting solid performance in core lottery operations, successful execution of divestitures, and significant capital returns.
Elanco Animal Health Incorporated (NYSE:ELAN) reported a double-digit surge in fourth-quarter revenue, fueled by the accelerating rollout of its "Big 6" blockbuster-potential products.
Xenia Hotels & Resorts (NYSE:XHR) reported a return to profitability in the final quarter of 2025, supported by a significant lift in revenue per available room (RevPAR) and an aggressive pruning of its hotel portfolio.
Henry Schein (NASDAQ:HSIC) reported a 7.7% increase in fourth-quarter net sales, reaching $3.4 billion as the company benefited from a rebound in high-margin dental equipment and specialty product demand.
Amer Sports (NYSE:AS) reported a "breakout year" for 2025, with fourth-quarter revenue surging 28% to $2.1 billion.
London-based Clarivate (NYSE:CLVT), a global provider of transformative intelligence solutions for scientific research, intellectual property, and life sciences, reported fourth-quarter and full-year 2025 results on February 24, 2026, highlighting enhanced cash generation, progress in subscription-based revenue mix, and strategic actions to streamline the portfolio and strengthen the balance sheet.
The Home Depot (NYSE:HD) reported a 3.8% decline in fourth-quarter sales to $38.2 billion, reflecting a continued normalization in the home improvement market following several years of heightened demand.
